Cargando…
Adenosine A(2A) receptors in Parkinson’s disease treatment
Latest results on the action of adenosine A(2A) receptor antagonists indicate their potential therapeutic usefulness in the treatment of Parkinson’s disease. Basal ganglia possess high levels of adenosine A(2A) receptors, mainly on the external surfaces of neurons located at the indirect tracts betw...
Autores principales: | Cieślak, Marek, Komoszyński, Michał, Wojtczak, Andrzej |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583202/ https://www.ncbi.nlm.nih.gov/pubmed/18438720 http://dx.doi.org/10.1007/s11302-008-9100-8 |
Ejemplares similares
-
Emerging role of extracellular nucleotides and adenosine in multiple sclerosis
por: Cieślak, Marek, et al.
Publicado: (2011) -
Role of purinergic receptors in the Alzheimer’s disease
por: Cieślak, Marek, et al.
Publicado: (2018) -
The role of purinergic signaling in the etiology of migraine and novel antimigraine treatment
por: Cieślak, Marek, et al.
Publicado: (2015) -
The Pharmacological Potential of Adenosine A(2A) Receptor Antagonists for Treating Parkinson’s Disease
por: Mori, Akihisa, et al.
Publicado: (2022) -
Arbutin effectively ameliorates the symptoms of Parkinson’s disease: the role of adenosine receptors and cyclic adenosine monophosphate
por: Zhao, Jie, et al.
Publicado: (2021)